Clinical trial
Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes…
NCT00232362 · Texas Tech University Health Sciences Center, Other · Withdrawn
Key facts
| NCT number | NCT00232362 |
|---|---|
| Title | Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus |
| Official title | Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus |
| Lead sponsor | Texas Tech University Health Sciences Center, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Pioglitazone (Actos), Anti-diabetic agent other than pioglitazone or rosiglitazone |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Oct 4, 2005 |
| Last update posted | Apr 13, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: